Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer

Published:2005 Issue:4 Volume:37 Page:212
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Shim Byoung Yong¹,Lee Kang Moon¹,Cho Hyeon-Min²,Kim Hyun Jin³,Cho Hong Joo¹,Yang Jinmo¹,Kim Jun-Gi²,Kim Hoon-Kyo¹

Affiliation:

1. Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.

2. Department of General Surgery, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.

3. Department of Diagnostic Radiology, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-37-212.pdf

Reference22 articles.

1. Ministry Health and Welfare. 2002 Annual report of Korea Central Cancer Registry (published in 2003)Available from URL: http://www.ncc.re.kr

2. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.

3. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.

4. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy;Journal of Oncology;2023-01-06

2. Targeting the SPHK1/HIF1 Pathway to Inhibit Colorectal Cancer Stem Cells Niche;Journal of Gastrointestinal Cancer;2019-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3